Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anna Bollinger, Céline K Stäuble, Chiara Jeiziner, Florine M Wiss, Kurt E Hersberger, Markus L Lampert, Henriette E Meyer zu Schwabedissen & Samuel S Allemann. (2023) Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study. Pharmacogenomics and Personalized Medicine 16, pages 693-706.
Read now
Read now
Cierra N. Sharp, Mark W. Linder & Roland Valdes$suffix/text()$suffix/text(). (2020) Polypharmacy: a healthcare conundrum with a pharmacogenetic solution. Critical Reviews in Clinical Laboratory Sciences 57:3, pages 161-180.
Read now
Read now
Frederick Zhang & Joseph Finkelstein. (2019) Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications. Pharmacogenomics and Personalized Medicine 12, pages 107-123.
Read now
Read now
Davide Seripa, Madia Lozupone, Eleonora Stella, Giulia Paroni, Paola Bisceglia, Maddalena La Montagna, Grazia D’onofrio, Carolina Gravina, Maria Urbano, Maria Giovanna Priore, Angela Lamanna, Antonio Daniele, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Francesco Panza. (2017) Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?. Expert Opinion on Drug Safety 16:12, pages 1373-1385.
Read now
Read now
Articles from other publishers (9)
Sherin Shaaban & Yuan Ji. (2023) Pharmacogenomics and health disparities, are we helping?. Frontiers in Genetics 14.
Crossref
Crossref
Evangelia Eirini Tsermpini, Zeina N. Al-Mahayri, Bassam R. Ali & George P. Patrinos. (2021) Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide. Human Genetics 141:6, pages 1137-1157.
Crossref
Crossref
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, Natalia Cacabelos & Juan C. Carril. (2021) Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. International Journal of Molecular Sciences 22:24, pages 13302.
Crossref
Crossref
Stephanie M. Matt. (2021) Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy. Brain, Behavior, & Immunity - Health 18, pages 100353.
Crossref
Crossref
Mingkwan Na Takuathung, Wannachai Sakuludomkan & Nut Koonrungsesomboon. (2021) The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis. Clinical Pharmacokinetics 60:10, pages 1291-1302.
Crossref
Crossref
P. C. D. Bank, J. J. Swen & H. J. Guchelaar. (2019) Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands. BMC Medicine 17:1.
Crossref
Crossref
Caroline Sirois, Nelia Sofia Domingues, Marie-Laure Laroche, Arsène Zongo, Carlotta Lunghi, Line Guénette, Edeltraut Kröger & Valérie Émond. (2019) Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health. Pharmacy 7:3, pages 126.
Crossref
Crossref
Jiazhen Liu & Joseph Finkelstein. (2017) Introducing pharmacogenomic decision support for medication risk assessment in people with polypharmacy. Introducing pharmacogenomic decision support for medication risk assessment in people with polypharmacy.
Jiazhen Liu, Sinan Zhu & Joseph Finkelstein. (2017) Pharmacogenomic-based medication risk assessment in people with polypharmacy. Pharmacogenomic-based medication risk assessment in people with polypharmacy.